Certified by Founder Lodge 
                                        
                                        a16z Bio + Health
 
                                                 United States  -  Menlo Park, CA 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $28,000,000
                                            6 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Backing bold entrepreneurs who are engineering biology and reimagining healthcare.
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Function Oncology | 
                                                            April, 13 ,2023 | Series A | $28,000,000 | 
   Orbital Therapeutics | 
                                                            April, 27 ,2023 | Series A | $270,000,000 | 
   Genesis Therapeutics | 
                                                            August, 22 ,2023 | Series B | $200,000,000 | 
   Gate Bioscience | 
                                                            November, 02 ,2023 | Series A | $60,000,000 | 
   Inductive Bio | 
                                                            December, 14 ,2023 | Seed | $4,300,000 | 
   Tome Biosciences | 
                                                            December, 14 ,2023 | Series B | $213,000,000 | 
                                                
  Function Oncology
  Orbital Therapeutics
  Genesis Therapeutics
  Gate Bioscience
  Inductive Bio
  Tome Biosciences
Founderpath
Truework
Finix
Farther
TeamApt Inc.
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)